Hyaluronan, CD44 and versican in epidermal keratinocyte tumours

British Journal of Dermatology

Volumn 148, Issue 1, 2003, Pages 86-94

  Karvinen, S ^a   Kosma, V M ^a   Tammi, M I ^a   Tammi, Raija ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Basal cell carcinoma; CD44; Hyaluronan; Squamous cell carcinoma; Versican

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; PARAFFIN; VERSICAN;

ARTICLE; BASAL CELL CARCINOMA; BIOTINYLATION; CARCINOMA IN SITU; CELL DIFFERENTIATION; CONNECTIVE TISSUE; CONTROLLED STUDY; CORNEA CELL; EPIDERMIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; STAINING; STROMA;

ANTIGENS, CD44; CARCINOMA; CARCINOMA IN SITU; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; HYALURONIC ACID; IMMUNOENZYME TECHNIQUES; KERATINOCYTES; LECTINS, C-TYPE; NEOPLASM PROTEINS; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; SKIN NEOPLASMS; VERSICANS;

EID: 0037240613     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05028.x     Document Type: Article

References (44)

1. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992; 6: 2397-404.
2. Knudson CB, Knudson W. Similar epithelial-stromal interactions in the regulation of hyaluronate production during limb morphogenesis and tumor invasion. Cancer Lett 1990; 52: 113-22.
3. Toole BP. Developmental role of hyaluronate. Connect Tissue Res 1982; 10: 93-100.
4. Turley EA, Austen L, Vandeligt K et al. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol 1991; 112: 1041-7.
5. Toole BP, Biswas C, Gross J. Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci USA 1979; 76: 6299-303.
6. Auvinen PK, Parkkinen JJ, Johansson RT et al. Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer 1997; 74: 477-81.
7. Anttila MA, Tammi RH, Tammi MI et al. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 2000; 60: 150-5.
8. Ropponen K, Tammi M, Parkkinen J et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 1998; 58: 342-7.
9. Tammi R, Ripellino JA, Margolis RU et al. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J Invest Dermatol 1988; 90: 412-14.
10. Tammi R, Ågren UM, Tuhkanen A-L et al. Hyaluronan metabolism in skin. Prog Histochem Cytochem 1994; 29: 1-81.
11. Wang C, Tammi M, Tammi R. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 1992; 98: 105-12.
12. Yasaka N, Furue M, Tamaki K. CD44 expression in normal human skin and skin tumors. J Dermatol 1995; 22: 88-94.
13. Karjalainen JM, Tammi RH, Tammi MI et al. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Am J Pathol 2000; 157: 957-65.
14. Weinstock MA. Epidemiology of nonmelanoma skin cancer: clinical issues, definitions, and classification. J Invest Dermatol 1994; 102 (Suppl.): 4-5S.
15. Simon JC, Heider KH, Dietrich A et al. Expression of CD44 iso-forms in human skin cancer. Eur J Cancer 1996; 32A: 1394-400.
16. Dingemans KP, Ramkema MD, Koopman G et al. The expression of CD44 glycoprotein adhesion molecules in basal cell carcinomas is related to growth pattern and invasiveness. Br J Dermatol 1999; 140: 17-25.
17. Prieto VG, Reed JA, McNutt NS et al. Differential expression of CD44 in malignant cutaneous epithelial neoplasms. Am J Dermatopathol 1995; 17: 447-51.
18. Nara Y, Kato Y, Torii Y et al. Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PGM / versican. Histochem J 1997; 29: 21-30.
19. Ricciardelli C, Quinn DI, Raymond WA et al. Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer. Cancer Res 1999; 59: 2324-8.
20. Wang C, Tammi M, Guo H et al. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 1996; 148: 1861-9.
21. Hirvikoski P, Tammi R, Kumpulainen E et al. Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma. Virchows Arch 1999; 434: 37-44.
22. Pirinen RT, Tammi RH, Tammi MI et al. Expression of hya-luronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung. Int J Cancer 1998; 79: 251-5.
23. Brecht M, Mayer U, Schlosser E et al. Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J 1986; 239: 445-50.
24. Yasuda M, Tanaka Y, Fujii K et al. CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells. Int Immunol 2001; 13: 1309-19.
25. Aitken K, Bagl DJ. Stretch-induced bladder smooth muscle cell (SMC) proliferation is mediated by RHAMM-dependent extracellular-regulated kinase (erk) signaling. Urology 2001; 57: 109.
26. Tanaka Y, Makiyama Y, Mitsui Y. Endothelin-1 is involved in the growth promotion of vascular smooth muscle cells by hyaluronic acid. Int J Cardiol 2000; 76: 39-47.
27. Pirinen R, Tammi R, Tammi M et al. Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer 2001; 95: 12-17.
28. Pirinen R, Hirvikoski P, Bohm J et al. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma. Hum Pathol 2000; 31: 1088-95.
29. Milstone LM, Hough-Monroe L, Kugelman LC et al. Epican, a heparan / chondroitin sulfate form of CD44, mediates cell-cell adhesion. J Cell Sci 1994; 107: 3183-90.
30. Koseki S, Ansai S, Aoki T et al. E-cadherin expression in skin tumors using an AMeX immunohistostaining method. J Dermatol 2000; 27: 307-11.
31. Kooy AJ, Tank B, Jong AA et al. Expression of E-cadherin, alpha-and beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma. Hum Pathol 1999; 30: 1328-35.
32. Papadavid E, Pignatelli M, Zakynthinos S et al. Abnormal immunoreactivity of the E-cadherin / catenin (-) complex in pre-malignant and malignant non-melanocytic skin tumours. J Pathol 2002; 196: 154-62.
33. Okamoto I, Kawano Y, Tsuiki H et al. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 1999; 18: 1435-46.
34. Kajita M, Itoh Y, Chiba T et al. Membrane-type 1 matrix metallo-proteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001; 153: 893-904.
35. Seiter S, Tilgen W, Herrmann K et al. Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Arch 1996; 428: 141-9.
36. Ågren UM, Tammi MI, Tammi RH. Developmentally programmed expression of hyaluronan in human skin and its appendages. J Invest Dermatol 1997; 109: 219-24.
37. Tuhkanen A-L, Ågren UM, Tammi MI et al. CD44 expression marks the onset of keratinocyte stratification, and mesenchymal maturation into fibrous dermis in fetal human skin. J Histochem Cytochem 1999; 47: 1617-24.
38. Kruger K, Blume-Peytavi U, Orfanos CE. Basal cell carcinoma possibly originates from the outer root sheath and / or the bulge region of the vellus hair follicle. Arch Dermatol Res 1999; 291: 253-9.
39. Tuhkanen A-L, Tammi M, Pelttari A et al. Ultrastructural analysis of human epidermal CD44 reveals preferential distribution on plasma membrane domains facing the hyaluronan-rich matrix pouches. J Histochem Cytochem 1998; 46: 241-8.
40. Collis L, Hall C, Lange L et al. Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action. FEBS Lett 1998; 440: 444-9.
41. Evanko SP, Wight T. Intracellular localization of hyaluronan in proliferating cells. J Histochem Cytochem 1999; 47: 1331-42.
42. Wennberg A-M. Basal cell carcinoma - new aspects of diagnosis and treatment. Acta Derm Venereol 2000; 209: 5-25.
43. Hunzelmann N, Schonherr E, Bonnekoh B et al. Altered immunohistochemical expression of small proteoglycans in the tumor tissue and stroma of basal cell carcinoma. J Invest Dermatol 1995; 104: 509-13.
44. Miller SJ. Biology of basal cell carcinoma. J Am Acad Dermatol 1991; 24: 161-75.